Pages that link to "Q42985164"
Jump to navigation
Jump to search
The following pages link to Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients. (Q42985164):
Displaying 14 items.
- Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C (Q27491326) (← links)
- Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients (Q33889885) (← links)
- Systemic cytokine and interferon responsiveness Patterns in HIV and HCV mono and co-infections (Q34439925) (← links)
- Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs (Q35033949) (← links)
- New hopes for HIV and HCV coinfection in 2004. (Q35912407) (← links)
- Gene expression profiles predict emergence of psychiatric adverse events in HIV/HCV-coinfected patients on interferon-based HCV therapy (Q36059746) (← links)
- Hepatitis C in patients co-infected with human immunodeficiency virus. A review and experience of a Brazilian ambulatory (Q36119738) (← links)
- Treatment of hepatitis C in HIV-coinfected patients (Q36409500) (← links)
- ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV. (Q36457789) (← links)
- Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV (Q36619816) (← links)
- New paradigms in the management of hepatitis C virus co-infections (Q36712169) (← links)
- Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells (Q37328900) (← links)
- Comparative efficacy, pharmacokinetic, pharmacodynamic activity, and interferon stimulated gene expression of different interferon formulations in HIV/HCV genotype-1 infected patients (Q39325002) (← links)
- Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV. (Q42985117) (← links)